Latest Operational Cash Flow News

Spacetalk Ltd reports robust growth in paid mobile subscribers and annual recurring revenue for Q2 FY25, underpinned by strategic international expansion and disciplined cost management.

Biotron Limited has engaged US-based C14 Consulting Group to drive strategic partnerships for its antiviral drug portfolio, including lead candidate BIT225, while advancing its Hepatitis B research.

Barton Gold Holdings reported a $1.74 million net cash outflow from operations in Q4 2024, ending the quarter with $7.01 million in cash and equivalents. The company’s available financing facilities and cash runway suggest cautious optimism for sustaining exploration activities.

SomnoMed Limited reported a solid cash flow performance for Q4 2024, with operating activities generating a net inflow of $1.525 million and ending the quarter with $18.5 million in cash reserves.

BSA Limited reported a robust Q2 FY2025 with revenue up 10.7% and EBITDA surging 31.5%, underpinned by a key contract extension with nbn. The company has upgraded its full-year EBITDA guidance, signaling confidence in sustained profitability.

Fertoz Limited reports solid Q4 2024 sales despite Canadian permit delays and plans a strategic rebrand to Canadian Phosphate Limited to align with its growth ambitions.

Raptis Group Limited reported stable income from its caretaking and letting operations for the December 2024 quarter, while navigating a personal injury claim and exploring a new residential resort project on the Gold Coast.

Raptis Group Limited reported a positive net cash inflow from operating activities of $54,509 for the quarter ended December 31, 2024, ending with $303,102 in cash and equivalents. The company recorded no investing or financing cash flows during the period.

CAQ Holdings Limited reported an 8% decrease in leasing revenue for the December 2024 quarter, as tenant negotiations continue amid uncertain government policies affecting the Hainan free trade port development.

InhalerX Limited reported a negative cash flow for the December quarter despite securing a substantial $38.5 million funding facility aimed at advancing its clinical trials. The company has yet to draw on this facility, maintaining a cautious cash position as it progresses its drug development programs.

Vonex Limited reported a net cash inflow of $779,000 from operating activities in Q4 2024, maintaining a solid cash position despite accelerated debt repayments following a change of control.

Talius Group reports a robust December quarter with $4.4 million revenue, positive operating cash flow, and a strategic $2.5 million capital raise, positioning the company for strong growth in 2025 amid evolving aged care legislation.